Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 3, 2008, Pages 682-690

  Nasr, Samih H ^a   D'Agati, Vivette D ^a   Park, Hye Ran ^b   Sterman, Paul L ^c   Goyzueta, Juan D ^d   Dressler, Robert M ^e   Hazlett, Shawn M ^f   Pursell, Robert N ^g   Caputo, Christopher ^h   Markowitz, Glen S ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b Medical Associates of Drexel Hill Inc   (United States)

^c SAINT PETER S UNIVERSITY HOSPITAL   (United States)

^d Catskill Regional Medical Center   (United States)

^e CHRISTIANA CARE HEALTH SYSTEM   (United States)

^f LEHIGH VALLEY HOSPITAL   (United States)

^g ST LUKE S HOSPITAL   (United States)

^h Queens Nassau Nephrology Services PLLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; PEROXIDASE; PREDNISOLONE;

ADULT; AGED; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; IMMUNOLOGY; KIDNEY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MIDDLE AGED; MORTALITY; NECROSIS; PATHOLOGY; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CYCLOPHOSPHAMIDE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NECROSIS; PEROXIDASE; PREDNISOLONE; RECURRENCE; TREATMENT OUTCOME;

EID: 44649136897     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04391007     Document Type: Article

References (26)

1. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65: 521-530, 2004
2. Jennette JC, Xiao H, Falk RJ: Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol 17: 1235-1242, 2006
3. Schwartz MM, Roberts JL, Lewis EJ: Necrotizing glomerulitis of systemic lupus erythematosus. Hum Pathol 14: 158-167, 1983
4. Ferrario F, Napodano P, Giordano A, Gandini E, Boeri R, D'Amico G: Peculiar type of focal and segmental lupus glomerulitis: Glomerulonephritis or vasculitis? Contrib Nephrol 99: 86-93, 1992
5. Akhtar M, al-Dalaan A, el-Ramahi KM: Pauci-immune necrotizing lupus nephritis: Report of two cases. Am J Kidney Dis 23: 320-325, 1994
6. Charney DA, Nassar G, Truong L, Nadasdy T: "Pauci-Immune" proliferative and necrotizing glomerulonephritis with thrombotic microangiopathy in patients with systemic lupus erythernatosus and lupus-like syndrome. Am J Kidney Dis 35: 1193-1206, 2000
7. Arahata H, Migita K, Izumoto H, Miyashita T, Munakata H, Nakamura H, Tominaga M, Origuchi T, Kawabe Y, Hida A, Taguchi T, Eguchi K: Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins. Clin Rheumatol 18: 77-81, 1999
8. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Lupus Nephritis Collaborative Study Group: Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59: 2156-2163, 2001
9. Hill GS, Delahousse M, Nochy D, Bariety J: Class IV-S versus class IV-G lupus nephritis: Clinical and morphologic differences suggesting different pathogenesis. Kidney Int 68: 2288-2297, 2005
10. Mittal B, Hurwitz S, Rennke H, Singh AK: New subcategories of class IV lupus nephritis: Are there clinical, histologic, and outcome differences? Am J Kidney Dis 44: 1050-1059, 2004
11. Masani NN, Imbriano LJ, D'Agati VD, Markowitz GS: SLE and rapidly progressive glomerulonephritis. Am J Kidney Dis 45: 950-955, 2005
12. Marshall S, Dressler R, D'Agati V: Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis. Am J Kidney Dis 29: 119-124, 1997
13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277, 1982
14. Sen D, Isenberg DA: Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus 12: 651-658, 2003
15. Galeazzi M, Morozzi G, Sebastiani GD, Bellisai F, Marcolongo R, Cervera R, De Ramòn Garrido E, Fernandez-Nebro A, Houssiau F, Jedryka-Goral A, Mathieu A, Papasteriades C, Piette JC, Scorza R, Smolen J: Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE. Clin Exp Rheumatol 16: 541-546, 1998
16. Lee SS, Lawton JW, Chan CE, Li CS, Kwan TH, Chau KF: Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol 31: 669-673, 1992
17. Chin HJ, Ahn C, Lim CS, Chung HK, Lee JG, Song YW, Lee HS, Han JS, Kim S, Lee JS: Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 20: 57-63, 2000
18. Pauzner R, Urowitz M, Gladman D, Gough J: Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. J Rheumatol 21: 1670-1673, 1994
19. Nishiya K, Chikazawa H, Nishimura S, Hisakawa N, Hashimoto K: Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol 16: 70-75, 1997
20. Finks SW, Finks AL, Self TH: Hydralazine-induced lupus: Maintaining vigilance with increased use in patients with heart failure. South Med J 99: 18-22, 2006
21. Ihle BU, Whitworth JA, Dowling JP, Kincaid-Smith P: Hydralazine and lupus nephritis. Clin Nephrol 22: 230-238, 1984
22. Choi HK, Merkel PA, Walker AM, Niles JL: Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: Prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 43: 405-413, 2000
23. Torffvit O, Thysell H, Nassberger L: Occurrence of auto-antibodies directed against myeloperoxidase and elastase in patients treated with hydralazine and presenting with glomerulonephritis. Hum Exp Toxicol 13: 563-567, 1994
24. Greenfield JR, McGrath M, Kossard S, Charlesworth JA, Campbell LV: ANCA-positive vasculitis induced by thioridazine: Confirmed by rechallenge. Br J Dermatol 147: 1265-1267, 2002
25. Physician's Desk Reference, 61st Ed., Montvale, NJ, Thomson PDR, 2007, p 2165
26. Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM: ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Am J Kidney Dis 36: 709-718, 2000